Provided by Tiger Trade Technology Pte. Ltd.

Biogen

214.28
+3.551.68%
Volume:116.04K
Turnover:24.72M
Market Cap:31.64B
PE:38.06
High:215.60
Open:209.92
Low:208.93
Close:210.73
52wk High:225.80
52wk Low:135.39
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.46
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.68
PE(LYR):24.38

Loading ...

Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says

MT Newswires Live
·
Jul 08

BofA Securities Adjusts Biogen Price Target to $217 From $203

MT Newswires Live
·
Jul 08

Biogen price target lowered to $222 from $224 at Morgan Stanley

TIPRANKS
·
Jul 08

Moderna Appoints Former Biogen CFO Michael Mcdonnell to Board, Audit Committee

Reuters
·
Jul 08

Biogen Inc. : Bofa Global Research Raises Price Objective to $217.00 from $203.00

THOMSON REUTERS
·
Jul 08

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Jul 08

Biogen is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 07

Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Biogen (BIIB)

TIPRANKS
·
Jul 07

Biogen Announces Investor Webcast from AAIC July 14, 2026

Reuters
·
Jul 07

Jefferies Adjusts Price Target on Biogen to $255 From $210

MT Newswires Live
·
Jul 07

Biogen : Jefferies Raises Target Price to $255 from $210

THOMSON REUTERS
·
Jul 07

Biogen price target raised to $157 from $150 at HSBC

TIPRANKS
·
Jul 06

How AAIC 2026 Alzheimer’s Data Releases Could Reframe Biogen (BIIB) Investors’ Long‑Term Thesis

Simply Wall St.
·
Jul 06

U.S. Research Roundup-east West Bancorp, First Citizens Bancshares, UMB Financial

Reuters
·
Jul 06

Biogen (BIIB) Could Be 1% Undervalued Before Key AAIC Alzheimer’s Data

Simply Wall St.
·
Jul 04

H.C. Wainwright Remains a Buy on Biogen (BIIB)

TIPRANKS
·
Jul 02

Biogen Says Research, Milestone Charges to Reduce Earnings in Q2, Q3

MT Newswires Live
·
Jul 02

Biogen Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 02

Biogen says Q2 results to include $164M expense on a pre-tax basis

TIPRANKS
·
Jul 02

Biogen Expects Q2 Acquired Ipr&d, Upfront and Milestone Expense of About $164 Million, Hits EPS by $0.95

Reuters
·
Jul 02